Accelerated partial breast irradiation using brachytherapy (APBIb) for the treatment of breast cancer has been rapidly increasing over the last several years in the U.S. as an alternative to standard whole-breast irradiation ...
Dec 16, 2011
0
0
Women who have had children (parous women) appear to have an increased risk of developing estrogen receptor-negative breast cancer, the subtype that carries a higher mortality rate and is more common in women of African ancestry. ...
Sep 16, 2014
0
0
Two new studies from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania offer hope for breast cancer survivors struggling with cancer-related pain and swelling, and point to ways ...
Nov 4, 2014
0
0
(HealthDay)—A daily, low dose of aspirin may increase the risk for progression and metastasis as well as mortality related to later-stage disease in adults aged 65 years and older who develop cancer, according to a study ...
Oct 5, 2020
0
13
Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the ...
Apr 3, 2015
0
59
One way many cancers grow resistant to treatment is by generating a web of blood vessels that are so jumbled they fail to provide adequate oxygen to the tumor. With oxygen starvation, the tumor gains a sort of cloaking device ...
Mar 16, 2015
0
224
While the use of antiangiogenesis drugs that block the growth of new blood vessels can improve the treatment of some cancers, clinical trials of their ability to prevent the development of new metastases have failed. Now ...
Jun 25, 2015
0
11
An international study led by The University of Melbourne has confirmed that long-term regular taking of aspirin or ibuprofen reduces the risk of bowel cancer by more than half for people with the genetic mutation causing ...
Jun 26, 2015
0
159
Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein. However, not all of these patients respond ...
Apr 28, 2015
0
195
The study was led by researchers at the National Cancer Institute (NCI)—designated Albert Einstein Cancer Center of Albert Einstein College of Medicine of Yeshiva University and Montefiore Einstein Center for Cancer Care ...
Jun 3, 2014
0
0
